tiprankstipranks
Dr. Agarwal's Health Care Ltd. (IN:AGARWALEYE)
:AGARWALEYE
India Market

Dr. Agarwal's Health Care Ltd. (AGARWALEYE) Ratios

0 Followers

Dr. Agarwal's Health Care Ltd. Ratios

IN:AGARWALEYE's free cash flow for Q2 2026 was ₹0.31. For the 2026 fiscal year, IN:AGARWALEYE's free cash flow was decreased by ₹ and operating cash flow was ₹0.15. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.43 1.66 1.85 1.03 1.10
Quick Ratio
1.26 1.49 1.72 0.91 0.94
Cash Ratio
0.41 0.54 0.27 0.42 0.48
Solvency Ratio
0.22 0.18 0.20 0.19 0.17
Operating Cash Flow Ratio
0.57 0.69 0.83 0.77 0.80
Short-Term Operating Cash Flow Coverage
2.44 3.70 4.43 4.61 4.53
Net Current Asset Value
₹ -11.12B₹ -9.51B₹ -6.23B₹ -8.56B₹ -5.65B
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.26 0.35 0.47 0.60
Debt-to-Equity Ratio
0.51 0.51 0.72 1.36 2.91
Debt-to-Capital Ratio
0.34 0.34 0.42 0.58 0.74
Long-Term Debt-to-Capital Ratio
0.07 0.08 0.19 0.33 0.53
Financial Leverage Ratio
1.96 1.97 2.06 2.90 4.83
Debt Service Coverage Ratio
2.56 2.27 2.21 2.39 2.14
Interest Coverage Ratio
4.31 6.42 5.13 1.95 1.81
Debt to Market Cap
0.02 0.02 0.03 0.03 0.02
Interest Debt Per Share
34.13 36.10 34.74 30.36 21.70
Net Debt to EBITDA
1.36 1.41 1.90 2.57 2.65
Profitability Margins
Gross Profit Margin
40.13%57.94%28.93%29.13%27.45%
EBIT Margin
16.39%15.70%20.84%15.30%14.69%
EBITDA Margin
29.55%29.19%33.79%27.93%28.21%
Operating Profit Margin
20.37%40.85%38.69%14.66%12.74%
Pretax Profit Margin
11.67%9.34%10.55%8.22%8.16%
Net Profit Margin
6.38%4.88%7.63%9.26%5.42%
Continuous Operations Profit Margin
8.13%6.45%7.14%10.16%6.21%
Net Income Per EBT
54.68%52.21%72.34%112.57%66.41%
EBT Per EBIT
57.26%22.87%27.27%56.10%64.08%
Return on Assets (ROA)
3.33%2.27%3.65%5.16%3.67%
Return on Equity (ROE)
6.92%4.47%7.55%14.95%17.75%
Return on Capital Employed (ROCE)
12.10%21.88%21.77%9.78%10.80%
Return on Invested Capital (ROIC)
8.17%14.41%12.41%9.20%7.63%
Return on Tangible Assets
4.83%3.37%4.95%7.05%4.49%
Earnings Yield
0.92%0.62%0.82%0.76%0.31%
Efficiency Ratios
Receivables Turnover
14.30 13.85 320.61 13.23 12.19
Payables Turnover
7.24 4.70 5.76 5.52 4.33
Inventory Turnover
15.09 8.97 15.19 15.52 11.73
Fixed Asset Turnover
1.16 1.15 1.16 1.12 1.27
Asset Turnover
0.52 0.47 0.48 0.56 0.68
Working Capital Turnover Ratio
20.11 5.12 7.38 67.01 54.50
Cash Conversion Cycle
-0.71 -10.55 -38.22 -15.01 -23.14
Days of Sales Outstanding
25.52 26.36 1.14 27.59 29.95
Days of Inventory Outstanding
24.18 40.71 24.03 23.52 31.12
Days of Payables Outstanding
50.41 77.62 63.38 66.12 84.21
Operating Cycle
49.70 67.07 25.16 51.11 61.07
Cash Flow Ratios
Operating Cash Flow Per Share
8.31 11.18 11.25 7.58 5.34
Free Cash Flow Per Share
1.57 0.77 3.70 2.45 3.05
CapEx Per Share
6.74 10.42 7.55 5.13 2.30
Free Cash Flow to Operating Cash Flow
0.19 0.07 0.33 0.32 0.57
Dividend Paid and CapEx Coverage Ratio
1.23 1.07 1.48 1.47 2.33
Capital Expenditure Coverage Ratio
1.23 1.07 1.49 1.48 2.33
Operating Cash Flow Coverage Ratio
0.27 0.34 0.36 0.27 0.27
Operating Cash Flow to Sales Ratio
0.13 0.19 0.26 0.23 0.24
Free Cash Flow Yield
0.36%0.17%0.92%0.61%0.76%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
108.37 160.87 121.45 131.25 327.64
Price-to-Sales (P/S) Ratio
6.94 7.85 9.27 12.15 17.76
Price-to-Book (P/B) Ratio
7.07 7.19 9.16 19.62 58.15
Price-to-Free Cash Flow (P/FCF) Ratio
277.25 589.13 108.67 164.00 131.75
Price-to-Operating Cash Flow Ratio
52.11 40.51 35.70 52.98 75.15
Price-to-Earnings Growth (PEG) Ratio
11.67 43.43 -10.32 0.88 -1.95
Price-to-Fair Value
7.07 7.19 9.16 19.62 58.15
Enterprise Value Multiple
24.86 28.29 29.34 46.08 65.62
Enterprise Value
145.18B 141.29B 132.06B 130.80B 128.69B
EV to EBITDA
24.86 28.29 29.34 46.08 65.62
EV to Sales
7.35 8.26 9.91 12.87 18.51
EV to Free Cash Flow
293.29 619.96 116.21 173.70 137.28
EV to Operating Cash Flow
55.38 42.63 38.17 56.11 78.31
Tangible Book Value Per Share
26.71 24.79 21.57 5.45 1.53
Shareholders’ Equity Per Share
61.23 62.99 43.82 20.47 6.91
Tax and Other Ratios
Effective Tax Rate
0.30 0.31 0.40 -0.23 0.24
Revenue Per Share
62.67 57.74 43.31 33.05 22.61
Net Income Per Share
4.00 2.82 3.31 3.06 1.23
Tax Burden
0.55 0.52 0.72 1.13 0.66
Interest Burden
0.71 0.60 0.51 0.54 0.56
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.08 0.17 0.02 0.02 0.03
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 0.00
Income Quality
1.81 3.97 2.46 2.79 2.89
Currency in INR